These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 23032416)

  • 1. Preserved CD4 T-cell telomere length during long-lasting HIV-2 infection.
    Tendeiro R; Albuquerque AS; Foxall RB; Cavaleiro R; Soares RS; Baptista AP; Soares MV; Gomes P; Sousa AE
    AIDS; 2013 Jan; 27(2):289-92. PubMed ID: 23032416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low CD4 T-cell counts despite low levels of circulating HIV: insights from the comparison of HIV-1 infected patients with a discordant response to antiretroviral therapy to patients with untreated advanced HIV-2 disease.
    Albuquerque AS; Foxall RB; Cortesão CS; Soares RS; Doroana M; Ribeiro A; Lucas M; Antunes F; Victorino RM; Sousa AE
    Clin Immunol; 2007 Oct; 125(1):67-75. PubMed ID: 17692571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Memory and naive-like regulatory CD4+ T cells expand during HIV-2 infection in direct association with CD4+ T-cell depletion irrespectively of viremia.
    Foxall RB; Albuquerque AS; Soares RS; Baptista AP; Cavaleiro R; Tendeiro R; Gomes P; Victorino RM; Sousa AE
    AIDS; 2011 Oct; 25(16):1961-70. PubMed ID: 21811143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increases in T cell telomere length in HIV infection after antiretroviral combination therapy for HIV-1 infection implicate distinct population dynamics in CD4+ and CD8+ T cells.
    Kaushal S; Landay AL; Lederman MM; Connick E; Spritzler J; Kuritzkes DR; Kessler H; Levine BL; St Louis DC; June CH
    Clin Immunol; 1999 Jul; 92(1):14-24. PubMed ID: 10413649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.
    Goicoechea M; Smith DM; Liu L; May S; Tenorio AR; Ignacio CC; Landay A; Haubrich R
    J Infect Dis; 2006 Jul; 194(1):29-37. PubMed ID: 16741879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased frequency of CD25dimCD4+ T-cells in HIV-2 infection, a naturally occurring attenuated form of HIV-1.
    Foxall RB; Soares RS; Albuquerque AS; Cortesão CS; Victorino RM; Sousa AE
    Clin Immunol; 2008 May; 127(2):158-67. PubMed ID: 18313362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central memory CD4 cells are an early indicator of immune reconstitution in HIV/AIDS patients with anti-retroviral treatment.
    Hua W; Jiao Y; Zhang H; Zhang T; Chen D; Zhang Y; Chen X; Wu H
    Immunol Invest; 2012; 41(1):1-14. PubMed ID: 21563924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune signatures for HIV-1 and HIV-2 induced CD4
    Salwe S; Singh A; Padwal V; Velhal S; Nagar V; Patil P; Deshpande A; Patel V
    BMC Infect Dis; 2019 Feb; 19(1):135. PubMed ID: 30744575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the frequency of interleukin (IL)-2-, interferon-gamma-, and IL-4-producing T cells in 2 diseases, human immunodeficiency virus types 1 and 2, with distinct clinical outcomes.
    Sousa AE; Chaves AF; Loureiro A; Victorino RM
    J Infect Dis; 2001 Sep; 184(5):552-9. PubMed ID: 11494161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of absolute CD4+ count in predicting co-infection with human T-lymphotropic virus type 1 in antiretroviral-naive HIV-infected patients.
    Gudo ES; Bhatt NB; Augusto O; Semá C; Savino W; Ferreira OC; Jani IV
    Int J STD AIDS; 2012 Oct; 23(10):717-23. PubMed ID: 23104746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient thymopoiesis contributes to the maintenance of peripheral CD4 T cells during chronic human immunodeficiency virus type 2 infection.
    Gautier D; Beq S; Cortesão CS; Sousa AE; Cheynier R
    J Virol; 2007 Nov; 81(22):12685-8. PubMed ID: 17804512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy.
    Keane NM; Price P; Lee S; Almeida CA; Stone SF; James I; French MA
    HIV Med; 2004 Nov; 5(6):407-14. PubMed ID: 15544692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+ T-lymphocyte nadir and the effect of highly active antiretroviral therapy on phenotypic and functional immune restoration in HIV-1 infection.
    Lange CG; Valdez H; Medvik K; Asaad R; Lederman MM
    Clin Immunol; 2002 Feb; 102(2):154-61. PubMed ID: 11846457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of correlation between HIV viral load and CD4+ T-cell counts in HIV/HTLV-1 co-infection in treatment naive Mozambican patients.
    Bhatt NB; Gudo ES; Semá C; Bila D; Di Mattei P; Augusto O; Garsia R; Jani IV
    Int J STD AIDS; 2009 Dec; 20(12):863-8. PubMed ID: 19948902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe immune dysregulation affects CD4⁺CD25(hi)FoxP3⁺ regulatory T cells in HIV-infected patients with low-level CD4 T-cell repopulation despite suppressive highly active antiretroviral therapy.
    Méndez-Lagares G; Pozo-Balado MM; Genebat M; García Pergañeda A; Leal M; Pacheco YM
    J Infect Dis; 2012 May; 205(10):1501-9. PubMed ID: 22457273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PD-1 and its ligand PD-L1 are progressively up-regulated on CD4 and CD8 T-cells in HIV-2 infection irrespective of the presence of viremia.
    Tendeiro R; Foxall RB; Baptista AP; Pinto F; Soares RS; Cavaleiro R; Valadas E; Gomes P; Victorino RM; Sousa AE
    AIDS; 2012 Jun; 26(9):1065-71. PubMed ID: 22441249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD38+CD8+ T-cells negatively correlate with CD4 central memory cells in virally suppressed HIV-1-infected individuals.
    Kolber MA
    AIDS; 2008 Oct; 22(15):1937-41. PubMed ID: 18784457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between the rate of CD4+ T cell decrease and the year of human immunodeficiency virus (HIV) type 1 seroconversion among persons enrolled in the Swiss HIV cohort study.
    Vanhems P; Lambert J; Guerra M; Hirschel B; Allard R
    J Infect Dis; 1999 Dec; 180(6):1803-8. PubMed ID: 10558934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy.
    Delobel P; Nugeyre MT; Cazabat M; Sandres-Sauné K; Pasquier C; Cuzin L; Marchou B; Massip P; Cheynier R; Barré-Sinoussi F; Izopet J; Israël N
    J Virol; 2006 Oct; 80(20):10229-36. PubMed ID: 17005700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WHO clinical staging of HIV infection and disease, tuberculosis and eligibility for antiretroviral treatment: relationship to CD4 lymphocyte counts.
    Teck R; Ascurra O; Gomani P; Manzi M; Pasulani O; Kusamale J; Salaniponi FM; Humblet P; Nunn P; Scano F; Harries AD; Zachariah R
    Int J Tuberc Lung Dis; 2005 Mar; 9(3):258-62. PubMed ID: 15786887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.